肝脏 ›› 2026, Vol. 31 ›› Issue (3): 336-340.

• 肝功能衰竭 • 上一篇    下一篇

血小板聚集功能对慢加急性肝衰竭患者预后的影响

张愉丽, 黄燕, 成思   

  1. 200120 上海 上海中医药大学附属曙光医院检验科
  • 收稿日期:2025-02-26 出版日期:2026-03-31 发布日期:2026-05-19
  • 通讯作者: 黄燕

The impact of platelet aggregation function on the prognosis of patients with acute-on-chronic liver failure

ZHANG Yu-li, HUANG Yan, CHENG Si   

  1. Department of Clinical Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200120, China
  • Received:2025-02-26 Online:2026-03-31 Published:2026-05-19
  • Contact: HUANG Yan

摘要: 目的 探讨血小板聚集功能对慢加急性肝衰竭(ACLF)患者预后的影响。方法 采用回顾性病例队列研究,收集2022年7月至2024年7月医院收治的120例ACLF患者的临床资料,根据其入院后28 d的生存情况分为病死组(n=60)与生存组(n=60)。所有患者入院时均检测血小板聚集功能,收集同期其他基线资料。采用单因素、多因素logistic回归模型分析影响ACLF患者预后的因素,绘制受试者工作特征(ROC)曲线分析血小板聚集功能对ACLF预后的预测效能。结果 病死组中性粒细胞与淋巴细胞比值(NLR)[(3.42±0.21)]、直接胆红素(DBil)[(179.62±11.05)μmol/L]、总胆红素(TBil)[(320.02±20.14)μmol/L]高于生存组[(3.21±0.17)、(169.33±8.61)μmol/L、(304.25±18.66)μmol/L],血小板聚集率(PAR)-肾上腺素(A)[(40.90±3.91)%]、PAR-胶原(COL)[(28.64±3.27)%]、PAR-二磷酸腺苷(ADP)[(30.22±3.75)%]水平低于生存组[(46.50±4.83)%、(33.52±3.41)%、(35.30±3.15)%],差异有统计学意义(P<0.05)。其余基线资料比较,差异无统计学意义(P>0.05)。多因素logistic回归性检验显示,PAR-A、PAR-COL、PAR-ADP、DBil是ACLF患者预后的影响因素[OR(95%CI):0.704(0.555~0.894)、0.523(0.367~0.745)、0.595(0.440~0.805)、1.120(1.011~1.241),P<0.05)]。ROC曲线显示,PAR-A、PAR-COL、PAR-ADP对ACLF患者预后具有中等预测价值,曲线下面积(AUC)分别为0.816、0.842、0.848,三者联合对ACLF患者预后具有高预测价值,AUC为0.968。结论 PAR-A、PAR-COL、PAR-ADP水平是影响ACLF患者预后的影响因素,且检测血小板聚集功能对预测患者预后具有一定指导意义。

关键词: 慢加急性肝衰竭, 血小板聚集功能, 总胆红素, 直接胆红素, 预后

Abstract: Objective To explore the impact of platelet aggregation function on the prognosis of patients with acute-on-chronic liver failure (ACLF). Methods A retrospective case cohort study was conducted in 120 ACLF patients admitted to Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine from July 2022 to July 2024. Based on their 28 day survival status after admission, they were divided into a mortality group (n=60) and a survival group (n=60). All patients were tested for platelet aggregation function upon admission, and other baseline data were collected at the same time. Univariate and multivariate logistic regression models were used to analyze the factors affecting the prognosis of these ACLF patients, and receiver operating characteristic (ROC) curves were drawn to analyze the predictive power of platelet aggregation function for the prognosis of ACLF patients. Results The neutrophil to lymphocyte ratio (NLR), direct bilirubin (DBil), and total bilirubin (TBil) levels in the mortality group were (3.42±0.21), (179.62±11.05) μmol/L, and (320.02±20.14) μmol/L, respectively, which were higher than those of (3.21±0.17), (169.33±8.61) μmol/L, and (304.25±18.66) μmol/L in the survival group. The levels of platelet aggregation rate (PAR)-adrenaline (A), PAR collagen (COL), and PAR adenosine diphosphate (ADP) were (40.9±3.91)%, (28.64±3.27)%, and (30.22±3.75)%, respectively, which were lower than those of [(46.50±4.83)%, (33.52±3.41)%, and (35.30±3.15)% in the survival group, and the difference was statistically significant (P<0.05). The comparison of other baseline data showed no statistical significant difference (P>0.05). By multivariate logistic regression analysis it was shown that PAR-A, PAR-COL, PAR-ADP, and DBil were prognostic factors for ACLF patients [OR (95% CI)=0.704 (0.555~0.894), 0.523 (0.367~0.745), 0.595 (0.440~0.805), and 1.120 (1.011~1.241), P<0.05]. The ROC curve analysis showed that PAR-A, PAR-COL, and PAR-ADP had moderate predictive value for the prognosis of ACLF patients, with areas under the curve (AUC) of 0.816, 0.842, and 0.848, respectively. The combination of these three factors had high predictive value for the prognosis of ACLF patients, with AUC of 0.968. Conclusion The levels of PAR-A, PAR-COL, and PAR-ADP are influencing factors for the prognosis of ACLF patients, and the detection of platelet aggregation function is helpful in predicting patients′ prognosis, which has certain clinical guiding significance.

Key words: Acute-on-chronic liver failure, Platelet aggregation function, Total bilirubin, Direct bilirubin, Prognosis